Looking to fast-track your Pharm/BioPharm development?

Accelerate with confidence and stay ahead of the curve

with winning foundations of proven expertise.

Expert Pharm/BioPharm Products & CTDMO Services

Pharma & Biopharma Raw Material Solutions

Explore our integrated Pharm/BioPharm product & CTDMO Service Solutions

Expert Pharm/BioPharm Products & CTDMO Services

Pharma & Biopharma Raw Material Solutions

For traditional and novel modalities

mRNA

Small molecules

mAb

ADC

VGT

The Life Science Business of Merck operates as MilliporeSigma in the US and Canada.

© 2024 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. Merck, Millipore and the vibrant M are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources.

Disclaimer: The Life Science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.

Go to article: Home | The GLP-1 drug shortage is over. What’s next for the compounders?Go to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: MilliporeSigmaGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Molnar-Institute Company InsightGo to article: Molnar-InstituteGo to article: ZETAGo to article: In DepthGo to article: The GLP-1 drug shortage is over. What’s next for the compounders?Go to article: Big pharma faces headwinds in China as vaccine sales declineGo to article: How can pharma manage rising trial costs?Go to article: Can AI replace medical writers? Experts say not immediatelyGo to article: Saving shelved ultra-rare therapies through unorthodox fundingGo to article: Do in vivo CAR-T cell therapies have the potential to overtake ex vivo CAR-Ts?Go to article: Weight loss implants to increase compliance and cut admin burden for patientsGo to article: Greens Company InsightGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Buyer's GuidesGo to article: Next issue